Literature DB >> 17912659

[Socioeconomic relevance of osteoarthritis in Germany].

H Merx1, K E Dreinhöfer, K-P Günther.   

Abstract

AIM OF STUDY: The aim of this study was to summarise the impact of medical care and related costs due to the treatment of osteoarthritis in Germany.
MATERIAL AND METHODS: Data from different health care institutions, government authorities and public health insurances for the year 2002 were analysed. Amount and cost of acute and rehabilitation treatments (in-patient as well as out-patient), sickness leave and early retirement related to osteoarthritis were estimated.
RESULTS: Advanced hip and knee osteoarthritis have a high socioeconomic impact in Germany. The number of people affected is growing, as is the overall incidence of joint replacement, especially knee arthroplasties and the percentage of in-patient rehabilitation for osteoarthritis.
CONCLUSION: Our study confirms that the direct and indirect costs attributable to osteoarthritis are substantial and the resulting socioeconomic burden is significant. Since age is a major risk factor for osteoarthritis, the demographic changes will lead to an increased need for medical treatment of osteoarthritis patients in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17912659     DOI: 10.1055/s-2007-965552

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  11 in total

1.  [Orthopaedic and trauma surgical care until 2050. Analysis of the utilization behavior for relevant diseases and derivation of the number of medical service providers].

Authors:  T Petzold; E Haase; F U Niethard; J Schmitt
Journal:  Orthopade       Date:  2016-02       Impact factor: 1.087

Review 2.  Clinical outcome after microfracture of the knee: a meta-analysis of before/after-data of controlled studies.

Authors:  Lukas Negrin; Florian Kutscha-Lissberg; Gerald Gartlehner; Vilmos Vecsei
Journal:  Int Orthop       Date:  2011-10-04       Impact factor: 3.075

Review 3.  [Musculoskeletal pain].

Authors:  H-R Casser; H-G Schaible
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

4.  Functional capacity of people with early osteoarthritis: a comparison between subjects from the cohort hip and cohort knee (CHECK) and healthy ageing workers.

Authors:  H J Bieleman; M W van Ittersum; J W Groothoff; J C M Oostveen; F G J Oosterveld; C P van der Schans; R Soer; M F Reneman
Journal:  Int Arch Occup Environ Health       Date:  2010-05-21       Impact factor: 3.015

Review 5.  [Sports and osteoarthrosis].

Authors:  M Schäfer; K Dreinhöfer
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

Review 6.  Surgical options for patients with osteoarthritis of the knee.

Authors:  Jörg Lützner; Philip Kasten; Klaus-Peter Günther; Stephan Kirschner
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

7.  [Prevalence of musculoskeletal complaints and self-reported joint osteoarthritis in the population of Herne : a telephone survey].

Authors:  U Thiem; J Schumacher; J Zacher; G-R Burmester; L Pientka
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 8.  Epidemiological evidence for work load as a risk factor for osteoarthritis of the hip: a systematic review.

Authors:  Sandra I Sulsky; Laura Carlton; Frank Bochmann; Rolf Ellegast; Ulrich Glitsch; Bernd Hartmann; Dirk Pallapies; D Seidel; Yi Sun
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

9.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

10.  Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, Germany.

Authors:  Ulrich Thiem; Rainer Lamsfuß; Sven Günther; Jochen Schumacher; Christian Bäker; Heinz G Endres; Josef Zacher; Gerd R Burmester; Ludger Pientka
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.